A growth hormone-releasing peptide promotes mitochondrial biogenesis and a fat burning-like phenotype through scavenger receptor CD36 in white adipocytes.
Rodrigue-Way. Amélie A; Demers. Annie A; Ong. Huy H; Tremblay. André A
Key Findings
- Hexarelin treatment reduces lipid stores in 3T3âL1 white adipocytes without changing CD36 levels.
- Genes linked to fattyâacid oxidation and thermogenesis (PPARÎł targets, CPTâ1, UCPâ1, PGCâ1α) are upâregulated after hexarelin exposure.
- Mitochondria become larger with dense cristae and higher cytochrome c oxidase activity, indicating enhanced oxidative capacity.
- In mice, hexarelin induces a brownâfatâlike phenotype in epididymal white fat, an effect that disappears in CD36ânull mice.
Practical Outcomes
- Hexarelin may act as a âfatâbrowningâ agent that could boost metabolic rate and support fat loss, but the evidence is limited to cells and mice. No human dosing, safety, or longâterm data exist, so any selfâexperiment should be considered highly experimental and approached with caution.
Summary
A study in mouse fat cells and mice shows that hexarelin, a growthâhormoneâreleasing peptide, can make white fat act more like brown fat â it burns more fat, builds more mitochondria, and turns on âheatâmakingâ genes. This effect needs the CD36 receptor and was not seen in mice that lack CD36.
Abstract
Whereas the uptake of oxidized lipoproteins by scavenger receptor CD36 in macrophages has been associated with foam cell formation and atherogenesis, little is known about the role of CD36 in regulating lipid metabolism in adipocytes. Here we report that treatment of 3T3-L1 adipocytes with hexarelin, a GH-releasing peptide that interacts with CD36, resulted in a depletion of intracellular lipid content with no significant change in CD36 expression. Microarray analysis revealed an increased pattern in several genes involved in fatty acid mobilization toward the mitochondrial oxidative phosphorylation process in response to hexarelin. Interestingly, many of these up-regulated genes are known targets of peroxisomal proliferator-activated receptor (PPAR)-gamma, such as FATP, CPT-1, and F(1)-ATPase, suggesting that adipocyte response to hexarelin may involve PPARgamma activation. Expression studies also indicate an increase in thermogenic markers PPARgamma coactivator 1alpha and uncoupling protein-1, which are normally expressed in brown adipocytes. Electron microscopy of hexarelin-treated 3T3-L1 adipocytes showed an intense and highly organized cristae formation that spans the entire width of mitochondria, compared with untreated cells, and cytochrome c oxidase activity was enhanced by hexarelin, two features characteristic of highly oxidative tissues. A similar mitochondrial phenotype was detected in epididymal white fat of mice treated with hexarelin, along with an increased expression of thermogenic markers that was lost in treated CD36-null mice, suggesting that the ability of hexarelin to promote a brown fat-like phenotype also occurs in vivo and is dependent on CD36. These results provide a potential role for CD36 to impact the overall metabolic activity of fat usage and mitochondrial biogenesis in adipocytes.
Study Information
pubmed
2006
2006-11-30T00:00:00.000Z
10.1210/en.2006-0975